HBM Healthcare Investments is a Swiss investment company listed on the SIX Swiss Exchange (ticker: HBMN) that holds a globally diversified portfolio of private and public healthcare companies, focusing on human medicine, biotechnology, medical technology and diagnostics.[1][2]
Design and History
HBM Healthcare Investments’ visual identity is closely tied to that of HBM Partners AG, the firm that acts as its investment advisor.[3] At the end of 2023, HBM Partners AG received a brand refresh and a contemporary visual appearance that was designed to visually reflect the strategic relationship between the two companies.[4] The rebranding included a website update and business cards with QR codes.[4]
This was not the first visual overhaul for the HBM group. In the summer of 2011, HBM BioVentures, a predecessor entity in the HBM group, refreshed its visual appearance across its website, business and quarterly reports and corporate presentation. The stated goal of that redesign was to translate the company’s focused approach to investment into a simple, sober and fresh look.[5] The 2011 project was handled by designer Kim Küng for design and Weber-Thedy Corporate & Financial Communications for project management.[5]
Meaning and Symbolism
Documented symbolism for the current HBM Healthcare Investments mark is limited. The 2023 refresh was described as giving the brand a contemporary appearance that visually takes up the strategic kinship between HBM Partners AG and HBM Healthcare Investments.[4] The earlier 2011 redesign of HBM BioVentures was explicitly intended to convey a simple, sober and fresh look that mirrored the company’s focused investment approach.[5]
Logo Index is an independent educational archive covering logos, visual identities and graphic design history. All trademarks and brand assets remain the property of their respective owners.
